LNTH
Price:
$90.52
Market Cap:
$6.29B
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also of...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2015-06-25
Stock Exchange
NASDAQ
Ticker
LNTH
According to Lantheus Holdings, Inc.’s latest financial reports and current stock price. The company's current ROE is 43.11%. This represents a change of 294.67% compared to the average of 10.92% of the last 4 quarters.
The mean historical ROE of Lantheus Holdings, Inc. over the last ten years is 62.71%. The current 43.11% ROE has changed -31.26% with respect to the historical average. Over the past ten years (40 quarters), LNTH's ROE was at its highest in in the December 2017 quarter at 417.01%. The ROE was at its lowest in in the December 2022 quarter at -26.65%.
Average
62.71%
Median
7.12%
Minimum
-25.12%
Maximum
529.75%
Discovering the peaks and valleys of Lantheus Holdings, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 537.85%
Maximum Annual ROE = 529.75%
Minimum Annual Increase = -2208.48%
Minimum Annual ROE = -25.12%
Year | ROE | Change |
---|---|---|
2023 | 40.04% | 537.85% |
2022 | 6.28% | -140.90% |
2021 | -15.35% | 485.74% |
2020 | -2.62% | -109.48% |
2019 | 27.63% | -51.58% |
2018 | 57.07% | -89.23% |
2017 | 529.75% | -2208.48% |
2016 | -25.12% | -415.70% |
2015 | 7.96% | 434.74% |
2014 | 1.49% | -94.31% |
The current ROE of Lantheus Holdings, Inc. (LNTH) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
10.32%
5-year avg
11.20%
10-year avg
62.71%
Lantheus Holdings, Inc.’s ROE is less than Neurocrine Biosciences, Inc. (15.68%), greater than Deciphera Pharmaceuticals, Inc. (-52.42%), greater than Ironwood Pharmaceuticals, Inc. (-7.63%), less than Alkermes plc (26.49%), greater than Avadel Pharmaceuticals plc (-93.32%), less than ANI Pharmaceuticals, Inc. (0%), greater than Dr. Reddy's Laboratories Limited (-1.60%), less than Collegium Pharmaceutical, Inc. (18.58%), less than Pacira BioSciences, Inc. (40.81%), greater than Alvotech (-10.70%), less than Catalent, Inc. (69.49%), greater than Amphastar Pharmaceuticals, Inc. (-11.44%), less than Journey Medical Corporation (22.92%), greater than Aquestive Therapeutics, Inc. (-132.10%), less than Dynavax Technologies Corporation (62.93%), less than null (3.19%),
Company | ROE | Market cap |
---|---|---|
15.68% | $12.72B | |
-52.42% | $2.21B | |
-7.63% | $550.50M | |
26.49% | $4.66B | |
-93.32% | $1.12B | |
0% | $1.20B | |
-1.60% | $11.84B | |
18.58% | $966.22M | |
40.81% | $810.34M | |
-10.70% | $3.35B | |
69.49% | $11.07B | |
-11.44% | $2.19B | |
22.92% | $112.18M | |
-132.10% | $415.77M | |
62.93% | $1.63B | |
3.19% | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Lantheus Holdings, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Lantheus Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Lantheus Holdings, Inc.'s ROE?
How is the ROE calculated for Lantheus Holdings, Inc. (LNTH)?
What is the highest ROE for Lantheus Holdings, Inc. (LNTH)?
What is the 3-year average ROE for Lantheus Holdings, Inc. (LNTH)?
What is the 5-year average ROE for Lantheus Holdings, Inc. (LNTH)?
How does the current ROE for Lantheus Holdings, Inc. (LNTH) compare to its historical average?